FDA inspection
Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site): FDA inspection ending Jan 13, 2023
FDA inspection 1195951 · Voluntary Action Indicated (VAI) · Dezhou
Key facts
| Inspection ID | 1195951 |
|---|---|
| Firm | Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) |
| FEI number | 3023338181 |
| Address | Circular Economy Demonstration Park |
| City | Dezhou |
| Fiscal year | 2023 |
| Inspection end date | Jan 13, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data